People with bipolar disorder have higher incidences of Parkinson's disease than those without the psychiatric condition. Manic and depressive episodes were associated with an elevated risk of developing Parkinson's disease.
Eating a Mediterranean-style diet can help protect the brain from tau protein build-up and brain shrinkage associated with Alzheimer's disease.
People with chronic kidney disease and reduced kidney function are at higher risk of developing dementia, a new study reports. Researchers found as kidney function decreased, the rate of dementia increased in those with kidney disease.
Researchers report obesity and excessive body fat around the middle is associated with lower grey matter volume in the brain. The study also found a link between obesity and shrinkage in specific brain areas.
During anomalously warm weather, people with multiple sclerosis have a 4% increased risk of having an emergency department visit. 3% of MS patients had an increased risk of inpatient hospital stays.
A new study reports people with Hepatitis B are up to 76% more likely to develop Parkinson's disease, and those with Hep C are 51% more likely to develop the disease.
Older adults who eat a diet rich in vegetables, fruits, fish and nuts have greater brain volume, a new study reveals. Researchers say diet can influence brain shrinkage and the development of neurodegenerative diseases as we age.
51% of COVID-19 patients report they experienced the loss of smell and taste up to five months after infection. On average, once their senses were restored, people reported a loss in sensitivity to smell and taste.
··6 min read
Axon myelination is significantly disrupted in patients with Alzheimer's disease. Researchers also found brain cells of men and women vary significantly in how their genes respond to the neurodegenerative disease.
According to researchers, Parkinson's disease may start in the gut and spread to the brain via the vagus nerve.
Twice daily vitamin D supplementation reduces symptoms of vertigo for those suffering BPPV.
A new study to be released in Neurology identifies caffeine levels in the blood as a potential biomarker for Parkinson's disease, Researchers discovered people with Parkinson's had lower levels of caffeine in their blood than people without the disease, even if they had consumed the same amount of caffeine.
